Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment-Reference-Cited by-同舟云学术

Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment

Published:2005-03 Issue:5 Volume:21 Page:1196-1204
ISSN:0953-816X
Container-title:European Journal of Neuroscience
language:en
Short-container-title:

Author:

Carta A. R.,Tronci E.,Pinna A.,Morelli M.

Publisher

Wiley

Subject

General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1460-9568.2005.03944.x/fullpdf

Reference72 articles.

1. Effects of conantokins on L-3,4-dihydroxyphenylalanine-induced behavior and immediate early gene expression;Adams;Eur. J. Pharmacol.,2000

2. Extensive co-occurrence of substance P and dynorphin in striatal projection neurons: an evolutionarily conserved feature of basal ganglia organization;Anderson;J. Comp. Neurol.,1990

3. Striatal fosB expression is causally linked with L-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease;Andersson;Neurobiol. Dis.,1999

4. Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa;Asin;J. Pharmacol. Exp. Ther.,1995

5. Effects of intralaminar thalamic nuclei lesion on glutamic acid decarboxylase (GAD65 and GAD67) and cytochrome oxidase subunit I mRNA expression in the basal ganglia of the rat;Bacci;Eur. J. Neurosci.,2002

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amphiregulin blockade decreases the levodopa‐induced dyskinesia in a 6‐hydroxydopamine Parkinson's disease mouse model;CNS Neuroscience & Therapeutics;2023-04-26

2. A Kinematic Data-Driven Approach to Differentiate Involuntary Choreic Movements in Individuals With Neurological Conditions;IEEE Transactions on Biomedical Engineering;2022-12

3. Antiparkinsonian-like effects of CPL500036, a novel selective inhibitor of phosphodiesterase 10A, in the unilateral rat model of Parkinson's disease;European Journal of Pharmacology;2021-11

4. Pathophysiological clues to therapeutic applications of glutamate mGlu5 receptor antagonists in levodopa-induced dyskinesia;European Journal of Pharmacology;2019-07

5. Differential Expression of Striatal ΔFosB mRNA and FosB mRNA After Different Levodopa Treatment Regimens in a Rat Model of Parkinson’s Disease;Neurotoxicity Research;2019-01-15